Global Stem Cell Institute & Covid Special (DR SONI On Fox News Channel 31)
Vitro BioPharma ( US Stem cell FDA compliant )
Provided by –Global Stem Cell institute ( GSCI )
CEO- Dr Maphi Carpenter PhD, MBA ( stem cell )
Medical Director -Dr Prabhat Soni MD, ABAAARM ( Stem Cell)
As a leading institution in the field of stem cell treatment and training, we pride ourselves on our commitment to advancing medical care through cutting-edge therapies. In 2020, our esteemed physician, Dr. Soni, became the first doctor in the United States to receive FDA approval for treating critically ill COVID-19 patients with stem cells under compassionate use.
Over the course of his tenure, Dr. Soni successfully treated 20 patients with severe COVID-19 symptoms, all of whom experienced significant improvement following treatment. Notably, even the most gravely ill patient – suffering from multiple organ failure, septic shock, deep coma, complete paralysis, and cardiac arrest – showed remarkable progress within weeks of receiving stem cell therapy. Against all odds, this patient went on to make a full recovery and was ultimately discharged to rehabilitation care.
We remain steadfast in our dedication to exploring the potential of stem cell treatment to revolutionize the medical field and offer new hope to those facing life-threatening conditions.
A patient who underwent stem cell treatment with Dr. Soni returned for a follow-up visit at our office six weeks post-treatment. We are pleased to report that the patient’s overall health has significantly improved, with the exception of paralysis in the left arm and leg due to a stroke.
Bone Marrow Stem Cell
Nebulizer Applies PRP Directly to Damaged Lungs
Dr. Prabhat Soni, MD was recently featured on the American Health Journal’s “DocTalk” YouTube Channel
NEW YORK, July 13, 2015 /PRNewswire/ — New York Based stem cell doctor with unique approach to make people lose weight by fixing hormone imbalance and sleep disorders beyond diet and exercise. Has offices in Manhattan, Queens and Brooklyn. Dr. Prabhat Soni was recently interviewed by the American Health Journal on his innovative Nebulized PRP treatment. The Manhattan doctor demonstrated the stem cell nebulizer mask and it’s effectiveness in treating lung problems, such as allergies, asthma and COPD. Dr. Soni’s interview will be included in a 13 part “DocTalk” series on YouTube called “Innovations in Medicine.”
“At American Health Journal, on PBS, we’re on the search for medical innovation, transformation and disruption as told by top doctors,” says AHJ Global Executive Producer, Michael Lesner. “Dr. Soni provided us with our first look at nebulized PRP, a look into the future of treatment for lung inflammation and injury.”
Platelet rich plasma, or PRP, holds immense promise for the treatment of injury and disease. Today, PRP is also a treatment option for lung inflammation and injury, due to the utilization of nebulized PRP through a nebulizer face mask. Nebulized PRP is available in a growing number of medical clinics nationwide.
PRP seems to be on everyone’s radar right now, and platelets are a key reason. Present naturally in everyone’s blood, platelets release growth factors and other immune system components to start the healing process when a person is injured. This is known as the inflammatory phase of healing.
PRP typically is injected at an injury site to stimulate the healing response with additional platelets. PRP has been used and proven effective in many condition such as osteoarthritis of joints, sexual dysfunction in both male and female patients (The “O” shot and The “P” Shot), wound care management, and facial rejuvenation, such as the famed “Vampire Facelift.” In The past PRP treatment therapies have shown promising results in aiding patients heal more quickly after neurosurgery, dental procedures, cardiothoracic surgery, cosmetic surgery and even Urology when addressing ED. Nebulized PRP provides an even newer delivery method that gives physicians another option for treating the lungs.
By allowing the patient to breathe aerosolized particles of nebulized PRP, the new delivery method increases the number of platelets into the lungs’ endothelial cells, which reduces inflammation and stimulates the healing process.
“We have become a leader in regenerative medicine,” said Matt Wallis, founder of IMAC Regeneration Centers. “With years of extensive research and experience, we are now utilizing platelet and stem cell therapies. The recent addition of nebulized platelet treatments has resulted in successful medical outcomes for patients with COPD, emphysema, and asthma.”
About Dr. Prabhat Soni
Dr. Prabhat Soni, MD, FCCP, DABSM, DABOM, ABAARM is the director at the stem cell institute in New York and is an Assistant Clinic Professor at Well Medical College-Cornell University.
Dr. Soni holds seven US board certifications. Has completed advanced fellowship training in stem cells with board certifications in anti-aging & regenerative medicine. His other board certifications include obesity, pain management, pulmonary, critical care, sleep, and internal medicine. Honored as a top sleep doctor of America by Sleep Review Magazine 2011, 2012, 2013.
Additionally, the US National Republican recognized Dr. Soni in 2008 Congressional Committee as an honorary chairman for the physician advisory board. Internationally, he has been honored by NRI Society Of India (Non Resident Indian Society) for outstanding achievements and contributions at the 31st International Congress on Republic Day in New Delhi.
He has also been the recipient of similar awards in 2012 at House of the Lords, London as well as the 2015 White House in Washington DC. Dr. Soni has been a past president of New York Community Hospital for 2 consecutive years, and listed in Who’s Who Madison as a distinguished member. Has been featured on prestigious health based programs such as American Health Front on CBS and American Health Journal on PBS.
Please note: All claims made regarding the efficacy of PRP lung treatment therapies as they pertain to lung conditions are based solely on independent physician interactions. The treatments, claims, and other information contained on this page have not been evaluated or approved by the FDA. Any individual is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information should be used for educational and informational use only.